Vitamins B6, B12, and folate: Association with plasma total homocysteine and risk of coronary atherosclerosis

Journal of the American College of Nutrition

Volumn 17, Issue 5, 1998, Pages 435-441

  Siri, Patty W ^a,b,c   Verhoef, Petra ^a   Kok, Frans J ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Coronary atherosclerosis; Folate; Methylenetetrahydrofolate reductase (MTHFR); Plasma total homocysteine; Vitamin B12; Vitamin B6

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEIC ACID; PYRIDOXINE; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PYRIDOXINE DEFICIENCY; RISK FACTOR; BLOOD; MIDDLE AGED; REGRESSION ANALYSIS;

ADULT; AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PYRIDOXINE; REGRESSION ANALYSIS; RISK FACTORS; VITAMIN B 12;

EID: 0031595492     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1998.10718790     Document Type: Article

References (31)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1057, 1995.
2. Stampfer MJ, Malinow MR, Willett WC, Newcomer L, Upson B, Ullmann D, Tisher P, Hennekens C: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992.
3. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE: Serum total homocysteine and coronary heart disease. Int J Epidemiol 24:704-709, 1995.
4. Verhoef P, Kok FJ, Kruyssen HACM, Schouten EG, Witteman JCM, Grobbee DE, Ueland PM, Refsum H: Plasma total homocysteine, B-vitamins and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 17:989-995, 1997.
5. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Rodney CPG, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL, Gore TB, Cornwell PE, Roseman JM: Plasma homocyst(e)ine, folate, and vitamin B12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59:940-948, 1994.
6. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG: Prospective study of serum total homocysteine concentrations and risk of stroke in middle-aged British men. Lancet 346:1395-398, 1995.
7. Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM: Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 15:232-240, 1995.
8. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC: Homocysteine metabolism and risk of myocardial infarction: relationship with vitamins B6, B12 and folate. Am J Epidem 143:845-859, 1996.
9. Giles WH, Kittner SJ, Anda RF, Croft JB, Casper ML: Serum folate and risk for ischemic stroke. Stroke 26:1166-1170, 1996.
10. Morrison HI, Schaubel D, Desmeules M, Wigle DT: Serum folate and risk of fatal coronary heart disease. JAMA 275:1893-1896, 1996.
11. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen SE, Kutner M, Topol EJ, Jacobsen DW: Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 92:2825-2830, 1995.
12. Kok FJ, Schrijver J, Hofman A, Witteman JC, Kruyssen DA, Remme WJ, Valkenburg HA: Low vitamin B6 status in patients with acute myocardial infarction. Am J Cardiol 63:513-516, 1989.
13. Willett WC: Does low vitamin B6 intake increase the risk of coronary heart disease? “Vitamin B6: Its Role in Health and Disease.” Boston: Alan R. Liss, Inc., 1985.
14. Brattström L, Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B, Hamfelt A: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Atherosclerosis 81:51-60, 1990.
15. Vermaak WJH, Barnard HC, Potgieter GM, Theron HD: Vitamin B6 and coronary artery disease: epidemiological observations and case studies. Atherosclerosis 63:235-238, 1987.
16. Rossouw JE, Labadarios D, Jooste PL, Shephard GS: Lack of a relationship between plasma pyridoxal phosphate levels and ischaemic heart disease. S Afr Med J 67:539-541, 1985.
17. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J: Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol 75:1107-1111, 1995.
18. Chasan-Taber L, Selhub J, Rosenberg IH, Malinow R, Terry P, Tishler PV, Willett W, Hennekens CH, Stampfer MJ: A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 15:136-143, 1996.
19. Ueland PM, Refsum H, Brattström L: Plasma homocysteine and cardiovascular disease. In Francis RB Jr (ed): “Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function”. New York: Marcel Dekker Inc., pp 183-236, 1992.
20. Selhub J, Miller JW: The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131-138, 1992.
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel L, Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113, 1995.
22. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9, 1996.
23. Harmon DL, Woodside JV, Yarnell JWG, McMaster D, Young IS, McCrum EE, Gey KF, Whitehead AS, Evans AE: The common ‘thermolabile’ variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 89: 571-577, 1996.
24. Verhoef P, Kok FJ, Kluijtmans LAJ, Blom HJ, Refsum H, Ueland PM, Kruyssen HACM: The 677C3T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105-113, 1997.
25. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM: Homocysteine and other thiols in plasma and urine; automated determination and sample stability. Clin Chem 39:263-271, 1993.
26. Myers BA, Dubick MA, Reynolds RD, Rucker RB: Effect of vitamin B6 (pyridoxine) deficiency on lung elastin cross-linking in perinatal and weanling rat pups. Biochem J 229:153-160, 1985.
27. Smolin LA, Benevenga NJ: Accumulation of homocyst(e)ine in vitamin B6 deficiency: a model for the study of cystathionine b-synthase deficiency. J Nutr 112:1264-1272, 1982.
28. Smolin LA, Crenshaw TD, Kurtycz D, Benevenga NJ: Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B6: relationship to atherosclerosis. J Nutr 113:2122-2133, 1983.
29. Mason JB, Miller JW. The effects of vitamin B12, B6 and folate on blood homocysteine levels. Ann NY Acad Sci 669:197-204, 1992.
30. Allen RH, Stabler SP, Savage DG, Lindenbaum J: Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 7:1344-1353, 1993.
31. Naurath HJ, Joosten E, Riezler R, Stabler SA, Allen RH, Lindenbaum J: Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346:85-89, 1995.